Coronavirus | Covaxin Phase III trial from November
Vaccine maker Bharat Biotech’s decision follows DCGI nod
Full Article
Coronavirus | Covaxin Phase III trial from November
Hindu
0 shares
1 views
You might like
Related news coverage
NA Proactive news snapshot: Medexus Pharmaceuticals, Next Green Wave, Humanigen, Canada Silver Cobalt Works, American Resources UPDATE...
Proactive Investors
Medexus Pharmaceuticals Inc (CVE:MDP) (OTCQX:MEDXF) revealed that it has struck an agreement with Geneva, Switzerland-based..
-
NA Proactive news snapshot: American Resources, MagicMed Industries, AIM ImmunoTech, Water Tower Research, Genprex UPDATE ...
Proactive Investors
-
NA Proactive news snapshot: Algernon Pharmaceuticals, Loop Insights, Esports Entertainment, BioSig Technologies …
Proactive Investors
-
States urged to adopt national approach: Niti Aayog on 'free vaccine'
Mid-Day
-
Covaxin Phase III trial from November
Hindu